Renal function in patients with acute decompensated de novo heart failure treated with the SGLT2 inhibitor empagliflozin: a secondary analysis of the EMPAG-HF trial
12 May 2024 (15:00 - 15:45)
Organised by: 
About the speaker
University hospital Jena, Jena (Germany)
6 More presentations in this session
Associate Professor H. Kim (Guri, KR)
Doctor J. Bogoviku (Jena, DE)
Doctor J. Bogoviku (Jena, DE)
Access the full session
The Event
Heart Failure 2024
12 May 2024
15:00 CET
